Table 1.
Patient | Diagnosis | RF | Sex | Age (years) | Age at diagnosis | Duration of arthritis (weeks) | DMARD | Corticosteroids | NSAID |
8 | RA | - | F | 57 | 4 years | 2 | Methotrexate 10 mg/week | No | Ketoprofen 200 mg/day |
9 | RA | - | F | 69 | 6 months | 52 | Methotrexate 10 mg/week | Prednisolone 7.5 mg/day | No |
10 | RA | + | F | 52 | 4 years | 1 | Methotrexate 17.5 mg/week s.c. | Prednisolone 5 mg/day | Ketoprofen 200 mg/day |
11 | RA | + | F | 64 | 4 days | 3 | No | Prednisolone 7.5 mg/day since 4 days | Diklofenac 150 mg/day |
12 | RA | + | F | 57 | 9 months | 26 | Methotrexate 7.5 mg/week | Prednisolone 7.5 mg/day | Indometacin 75 mg/day |
13 | RA | + | M | 66 | 10 weeks | n.a. | Methotrexate 10 mg/week | No | Diclofenac 50 mg on demand |
DMARD, disease-modifying anti-rheumatic drug; NSAID, non-steroidal anti-inflammatory drug; RA, rheumatoid arthritis; RF, rheumatoid factor serology; s.c., subcutaneous.